Literature DB >> 27652613

Targeting MYC: is it getting any easier?

Giovanna Zinzalla1.   

Abstract

Entities:  

Keywords:  MYC; anticancer therapy; protein–protein interactions

Year:  2016        PMID： 27652613     DOI： 10.4155/fmc-2016-0119

Source DB:  PubMed          Journal:  Future Med Chem        ISSN： 1756-8919            Impact factor:   3.808


× No keyword cloud information.
  4 in total

1.  Biophysical and Structural Methods to Study the bHLHZip Region of Human c-MYC.

Authors:  Giovanna Zinzalla
Journal:  Methods Mol Biol       Date:  2021

2.  Crystal Structures and Nuclear Magnetic Resonance Studies of the Apo Form of the c-MYC:MAX bHLHZip Complex Reveal a Helical Basic Region in the Absence of DNA.

Authors:  Susan Sammak; Najoua Hamdani; Fabrice Gorrec; Mark D Allen; Stefan M V Freund; Mark Bycroft; Giovanna Zinzalla
Journal:  Biochemistry       Date:  2019-07-11       Impact factor: 3.162

Review 3.  Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy.

Authors:  Xiaonan Zhang; Tobias Sjöblom
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-13

4.  The structure of INI1/hSNF5 RPT1 and its interactions with the c-MYC:MAX heterodimer provide insights into the interplay between MYC and the SWI/SNF chromatin remodeling complex.

Authors:  Susan Sammak; Mark D Allen; Najoua Hamdani; Mark Bycroft; Giovanna Zinzalla
Journal:  FEBS J       Date:  2018-10-01       Impact factor: 5.542
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.